Accuray Executive and Leadership Team

Steve La Neve, the Chief Executive Officer at Accuray, directs the overarching corporate strategy and global mission to transform radiation oncology through technological innovation. La Neve oversees the development of advanced medical devices that allow clinicians to target tumors with extreme precision. By aligning product development with the evolving needs of hospitals and cancer treatment centers, the Chief Executive Officer ensures that the organization maintains a competitive edge in the global medical device market. This leadership role involves constant collaboration with the Board to drive long-term growth and operational excellence. Through the implementation of adaptive treatment planning and real-time imaging integration, Steve La Neve supports the expansion of clinical capabilities for healthcare providers worldwide. Ultimately, La Neve secures the company's position as a leader in oncology by prioritizing patient outcomes and technological advancement across all international markets.

Ali Pervaiz, the Senior VP & Chief Financial Officer at Accuray, directs the financial strategy and capital allocation necessary to sustain the development of advanced radiation oncology systems. Pervaiz oversees the fiscal health of the organization, ensuring that resources support the manufacturing of innovative medical devices and the expansion of global market presence. By managing financial planning and analysis, the Senior VP & Chief Financial Officer provides the stability required for long-term investment in imaging and delivery technologies. This leadership role involves coordinating with other C-suite executives to align budgetary priorities with the company's mission of improving clinical outcomes. Through rigorous oversight of financial performance, Ali Pervaiz supports the company's ability to serve hospitals and cancer treatment centers effectively. Ultimately, Pervaiz secures the economic foundation that allows the organization to continue delivering precise cancer treatment solutions to patients who require specialized care.

Johannes Diebold, the Region President & General Manager (APAC) at Accuray, directs all commercial operations and market development initiatives across the Asia-Pacific region. Diebold oversees the distribution and implementation of radiation oncology systems, ensuring that hospitals and specialized facilities have access to advanced cancer treatment technology. By tailoring the company's product strategy to the specific regulatory and clinical needs of diverse APAC markets, the Region President & General Manager (APAC) drives regional growth and adoption. This leadership role involves building strong relationships with healthcare providers to expand the footprint of adaptive treatment planning. Through the management of local teams, Johannes Diebold ensures that the organization delivers consistent support and service excellence. Ultimately, Diebold strengthens the company's competitive position in the region by facilitating the integration of sophisticated imaging and delivery platforms into local cancer care workflows.

Kazuharu Tomari, the Region President & General Manager (Japan) at Accuray, directs the strategic expansion and operational management of the company's radiation oncology business within the Japanese market. Tomari oversees the deployment of high-precision medical devices, ensuring that local cancer treatment centers utilize the latest imaging and delivery technologies. By navigating the unique clinical landscape and regulatory requirements of Japan, the Region President & General Manager (Japan) ensures that the organization meets the specific needs of local healthcare providers. This leadership role involves fostering partnerships with medical institutions to enhance the quality of cancer care for patients. Through the effective management of regional resources, Kazuharu Tomari drives the adoption of adaptive therapy solutions across the country. Ultimately, Tomari secures the company's market leadership by delivering reliable, high-performance oncology systems that address the critical demand for precise tumor targeting in the Japanese healthcare sector.

Seth Blacksburg, the Senior Vice President, Chief Medical Officer, Chief Marketing Officer at Accuray, architects the clinical strategy and market positioning for radiation oncology systems. Blacksburg bridges the gap between complex medical requirements and commercial execution, ensuring that the company's platforms address critical challenges in cancer care. Overseeing the integration of sophisticated imaging and delivery technologies, the Senior Vice President, Chief Medical Officer, Chief Marketing Officer validates the efficacy of treatment solutions for diverse anatomical sites. This role involves translating clinical data into compelling market narratives that resonate with specialized radiation oncology facilities. By driving the adoption of adaptive therapy, Seth Blacksburg directly influences how healthcare providers utilize these tools to improve patient quality of life. Through strategic oversight of medical and marketing functions, Blacksburg ensures that the organization remains at the forefront of clinical innovation while expanding the reach of advanced cancer treatment solutions.

John Dunn, the Senior Vice President, Chief Information Officer at Accuray, directs the digital infrastructure and data systems that support the manufacturing and deployment of radiation oncology platforms. Dunn oversees the technological backbone required to integrate real-time imaging and adaptive planning software into the company's medical devices. By securing the integrity of clinical data and optimizing internal operational workflows, the Senior Vice President, Chief Information Officer ensures that global teams maintain seamless connectivity. This leadership role involves managing the cybersecurity frameworks necessary to protect sensitive patient information across hospital networks. Through the modernization of enterprise systems, John Dunn enables the organization to scale its technical capabilities and support complex treatment environments. Ultimately, Dunn drives the digital transformation of the company's service model, ensuring that healthcare providers receive reliable, high-performance technology to deliver precise cancer care to patients in diverse clinical settings.